These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1641114)

  • 1. Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma.
    Watts RG; Merchant RE
    Neurosurgery; 1992 Jul; 31(1):89-98; discussion 98-9. PubMed ID: 1641114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
    Kido G; Wright JL; Merchant RE
    J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.
    Watts RG; Wright JL; Atkinson LL; Merchant RE
    Neurosurgery; 1989 Aug; 25(2):202-8. PubMed ID: 2788827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an intratumoral injection of human recombinant tumor necrosis factor-alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model.
    Wright JL; Merchant RE
    Acta Neuropathol; 1997 Jan; 93(1):78-86. PubMed ID: 9006660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.
    Rice CD; Merchant RE
    J Neurooncol; 1992 May; 13(1):43-55. PubMed ID: 1613537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system.
    Kikuchi T; Joki T; Saitoh S; Hata Y; Abe T; Kato N; Kobayashi A; Miyazaki T; Ohno T
    Int J Cancer; 1999 Jan; 80(3):425-30. PubMed ID: 9935185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.
    Merchant RE; McVicar DW; Merchant LH; Young HF
    J Neurooncol; 1992 Jan; 12(1):75-83. PubMed ID: 1541981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
    Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats.
    Carson WE; Jakowatz JG; Yamamoto R; Fitzgerald T; Gupta S; Vayuvegula B; Lucci JA; Beckman MT; Dulkanchainun S; Granger GA
    J Immunother (1991); 1991 Apr; 10(2):131-40. PubMed ID: 2043593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect between intraneoplastic methotrexate and radiation on experimental intracerebral rat gliosarcoma.
    Wilkinson HA; Fujiwara T; Rosenfeld S
    Neurosurgery; 1994 Apr; 34(4):665-8; discussion 668. PubMed ID: 8008164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
    Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
    Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
    Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
    Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma.
    Kruse CA; Mitchell DH; Kleinschmidt-DeMasters BK; Bellgrau D; Eule JM; Parra JR; Kong Q; Lillehei KO
    J Neurooncol; 1993 Feb; 15(2):97-112. PubMed ID: 8509824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of local immunochemotherapy of head and neck cancer].
    Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1991 Dec; 94(12):1898-912. PubMed ID: 1779275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
    Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
    Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model.
    Goldberg SN; Saldinger PF; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Kruskal JB
    Radiology; 2001 Aug; 220(2):420-7. PubMed ID: 11477246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
    Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effect of intra-arterial tumor necrosis factor-alpha in rats with transplanted intracerebral glioma and its evaluation by MRI].
    Harada K; Yoshida J; Wakabayashi T; Sugita K; Kurisu K; Uozumi T; Zieroth BF; Takahashi M; Yamanaka T
    No Shinkei Geka; 1995 Dec; 23(12):1069-74. PubMed ID: 8927213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model for evaluating therapeutic response of combined cancer treatment modalities: applied to treatment of subcutaneously implanted brain tumors (N32 and N29) in Fischer rats with pulsed electric fields (PEF) and 60Co-gamma radiation (RT).
    Persson BR; Bauréus Koch C; Grafstrom G; Engstrom PE; Salford LG
    Technol Cancer Res Treat; 2003 Oct; 2(5):459-70. PubMed ID: 14529312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model.
    Yang FY; Lin GL; Horng SC; Chang TK; Wu SY; Wong TT; Wang HE
    IEEE Trans Ultrason Ferroelectr Freq Control; 2011 May; 58(5):964-70. PubMed ID: 21622052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.